NUSCA, ANNUNZIATA
 Distribuzione geografica
Continente #
AS - Asia 4.636
NA - Nord America 746
EU - Europa 461
OC - Oceania 31
AF - Africa 7
SA - Sud America 4
Totale 5.885
Nazione #
SG - Singapore 4.300
US - Stati Uniti d'America 735
CN - Cina 189
IT - Italia 136
HK - Hong Kong 107
DE - Germania 67
GB - Regno Unito 65
NL - Olanda 53
EE - Estonia 46
CZ - Repubblica Ceca 42
AU - Australia 31
IN - India 14
FI - Finlandia 12
CA - Canada 10
FR - Francia 10
VN - Vietnam 8
TR - Turchia 5
AT - Austria 4
BR - Brasile 4
ID - Indonesia 4
RO - Romania 4
ZA - Sudafrica 4
ES - Italia 3
MA - Marocco 3
PL - Polonia 3
SE - Svezia 3
TW - Taiwan 3
UA - Ucraina 3
CH - Svizzera 2
LT - Lituania 2
NO - Norvegia 2
PK - Pakistan 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
BE - Belgio 1
DO - Repubblica Dominicana 1
IL - Israele 1
IR - Iran 1
JP - Giappone 1
LU - Lussemburgo 1
RU - Federazione Russa 1
Totale 5.885
Città #
Ashburn 395
Singapore 136
Hong Kong 104
Boardman 88
Rome 77
Hefei 69
London 56
Tallinn 45
Amsterdam 40
Shanghai 36
Brno 31
Council Bluffs 31
Munich 29
Los Angeles 21
Perth 20
San Francisco 15
Washington 14
Seattle 11
West Jordan 10
Olomouc 9
Santa Clara 8
Milan 7
Bengaluru 6
Hanover 6
Jinan 6
Pune 6
The Dalles 6
Turku 6
Xi'an 6
Dallas 5
Helsinki 5
Guangzhou 4
Melbourne 4
New York 4
Nuremberg 4
Târgu Mureş 4
Zhengzhou 4
Aubin Grove 3
Borås 3
Brooklyn 3
Casablanca 3
Conroe 3
Frankfurt am Main 3
Montreal 3
Seichamps 3
Stuttgart 3
São Paulo 3
Taipei 3
Aberdeen 2
Ankara 2
Aversa 2
Basel 2
Beijing 2
Bologna 2
Canberra 2
Castagnole 2
Central 2
Centurion 2
Ciampino 2
Durham 2
Florence 2
Hamar 2
Hilo 2
Ho Chi Minh City 2
Krakow 2
Louisville 2
Mainz 2
North Bergen 2
Palermo 2
Qingdao 2
Quận Ninh Kiều 2
San Jose 2
Santiago De Compostela 2
Shenyang 2
Shijiazhuang 2
Sona 2
Springfield 2
Toronto 2
Vienna 2
Xiamen 2
Xiangtan 2
Zhoukou 2
Adelaide 1
Agawam 1
Alexandria 1
Anyang 1
Ardea 1
Atlanta 1
Baoding 1
Bazhou 1
Beauharnois 1
Bergamo 1
Berlin 1
Boston 1
Buffalo 1
Camden 1
Changzhou 1
Chennai 1
Chicago 1
Chongqing 1
Totale 1.447
Nome #
Circadian variations of platelet reactivity on clopidogrel in patients treated with elective percutaneous coronary intervention 400
Contrast-induced Acute Kidney Injury in Diabetic Patients and SGLT-2 Inhibitors: A Preventive Opportunity or Promoting Element? 201
Characterization of inflammatory profile by breath analysis in chronic coronary syndromes 197
Takotsubo Syndrome and Coronary Artery Disease: Which Came First-The Chicken or the Egg? 192
Designing the Optimal Procedure: Role of CT Scan in the Planning of Transcatheter Structural Heart Interventions 192
Changes of the Coronary Arteries and Cardiac Microvasculature With Aging: Implications for Translational Research and Clinical Practice 190
[The hybrid strategy for complete myocardial revascularization in the frail elderly patient]. 190
Prediction of type 4a myocardial infarction with the angiography-derived hemodynamic (ADDED) index 185
Current Applications and New Perspectives in Optical Coherence Tomography (OCT) Coronary Atherosclerotic Plaque Assessment: From PCI Optimization to Pharmacological Treatment Guidance 185
Carcinoid Pulmonary Valve Stenosis: Multimodality Imaging and Transcatheter Valve Implant With Prestenting Technique 183
Dexamethasone-eluting stents attenuate endothelial activation in patients with unstable coronary syndromes 180
Emerging from the Darkness. Sudden Cardiac Death in Cardiac Amyloidosis 179
3D transesophageal echocardiographic assessment of acute reverse remodeling of the tricuspid annulus after transcatheter edge-to-edge repair 178
Coronary Chronic Total Occlusion Revascularization: When, Who and How? 177
Leptin as predictor of cardiovascular events and high platelet reactivity in patients undergoing percutaneous coronary intervention 174
Dissecting intramyocardial hematoma masquerading as a pseudoaneurysm of left ventricular free wall: an unusual case of myocardial rupture 170
Antithrombotic treatment for valve prostheses: Which drug, which dose, and when? 165
Glycaemic Control in Patients Undergoing Percutaneous Coronary Intervention: What Is the Role for the Novel Antidiabetic Agents? A Comprehensive Review of Basic Science and Clinical Data 160
Current management and prognosis of patients with recurrent myocardial infarction 145
Relationship Between the Completeness of Revascularization and Myocardial Injury in Patients Treated With Percutaneous Coronary Intervention 145
Incretins-Based Therapies and Their Cardiovascular Effects: New Game-Changers for the Management of Patients with Diabetes and Cardiovascular Disease 132
Correction to: The Role of Angiogenesis and Arteriogenesis in Myocardial Infarction and Coronary Revascularization 88
Beyond the Calcium Score: What Additional Information from a CT Scan Can Assist in Cardiovascular Risk Assessment? 87
Combined procedure of transcatheter aortic valve replacement and coronary intravascular lithotripsy 86
Impact of oral anticoagulant regimens on occurrence of contrast-induced nephropathy in patients undergoing coronary angioplasty 85
Arrhythmias after COVID-19 Vaccination: Have We Left All Stones Unturned? 84
Prediction of 5-Year Mortality in Patients with Chronic Coronary Syndrome Treated with Elective Percutaneous Coronary Intervention: Role of the ACEF Score 84
Correlation between glycemic variability assessed by CGM and short-term outcome in patients undergoing percutaneous coronary intervention 80
Incremental role of glycaemic variability over HbA1c in identifying type 2 diabetic patients with high platelet reactivity undergoing percutaneous coronary intervention 78
Glycemic variability in the development of cardiovascular complications in diabetes 78
Integrating platelet reactivity in the age, creatinine and ejection fraction score to predict clinical outcomes following percutaneous coronary intervention in patients with chronic coronary syndrome: the PR-ACEF score 77
Incidence, diagnosis, and prognosis of myocarditis: does gender matter? 77
Relation of Platelet Indexes to Platelet Reactivity and Periprocedural Myocardial Infarction in Patients Who Underwent Percutaneous Coronary Angioplasty 76
Impact of burden and distribution of aortic valve calcification on the hemodynamic performance and procedural outcomes of a self-expanding, intra-annular transcatheter aortic valve system 74
Fractional Flow Reserve-Guided Coronary Revascularization: Evidence from Randomized and Non-Randomized Studies 74
Invasive Assessment of Coronary Microvascular Function 71
Impact of Mediterranean diet on metabolic and inflammatory status of patients with polyvascular atherosclerotic disease 64
The Spectrum of Coronary Artery Disease in Elite Endurance Athletes-A Long-Standing Debate: State-of-the-Art Review 59
Glycemic Variability Assessed by Continuous Glucose Monitoring and Short-Term Outcome in Diabetic Patients Undergoing Percutaneous Coronary Intervention: An Observational Pilot Study 58
Classification of Aortic Stenosis Patients via ECG-Independent Multi-Site Measurements of Cardiac-Induced Accelerations and Angular Velocities at the Skin Level 54
In Stent Neo-Atherosclerosis: Pathophysiology, Clinical Implications, Prevention, and Therapeutic Approaches 40
Eosinophilic Myocarditis: From Bench to Bedside 37
Instantaneous wave-free ratio-guided revascularization of non-culprit lesion in patients with ST-segment elevation myocardial infarction and multivessel coronary disease: design and rationale of the WAVE Registry 34
The Pivotal Role of Invasive Functional Assessment in Patients With Myocardial Infarction With Non-Obstructive Coronary Arteries (MINOCA) 31
The Role of Angiogenesis and Arteriogenesis in Myocardial Infarction and Coronary Revascularization 28
Who is the next for aortic valve implantation? Present and future indications 24
Tricuspid Valve Geometrical Changes in Patients with Functional Tricuspid Regurgitation: Insights from a CT Scan Analysis Focusing on Commissures 23
Indirect respiratory monitoring via single-lead wearable ECG: Influence of motion artifacts and devices on respiratory rate estimations 23
Effects of Finerenone on Cardiovascular and Chronic Kidney Diseases: A New Weapon against Cardiorenal Morbidity and Mortality-A Comprehensive Review 22
Usefulness of Adding Pre-procedural Glycemia to the Mehran Score to Enhance Its Ability to Predict Contrast-induced Kidney Injury in Patients Undergoing Percutaneous Coronary Intervention Development and Validation of a Predictive Model 22
Platelet Effects of Anti-diabetic Therapies: New Perspectives in the Management of Patients with Diabetes and Cardiovascular Disease 21
The butterfly effect: Restoring the tricuspid coaptation after clipping the antero-septal commissure 20
Prevalence and clinical impact of high platelet reactivity in patients with chronic kidney disease treated with percutaneous coronary intervention: An updated systematic review and meta-analysis 20
Percutaneous Repair of Atrial Functional Tricuspid Regurgitation in Cardiac Amyloidosis: Combining Linear With Lateral Thinking 20
SGLT-2 Inhibitors on Top of Current Pharmacological Treatments for Heart Failure: A Comparative Review on Outcomes and Cost Effectiveness 20
Usefulness of statin pretreatment to prevent contrast-induced nephropathy and to improve long-term outcome in patients undergoing percutaneous coronary intervention 19
Novel Antidiabetic Agents and Their Effects on Lipid Profile: A Single Shot for Several Cardiovascular Targets 18
Ranolazine Improves Glycemic Variability and Endothelial Function in Patients with Diabetes and Chronic Coronary Syndromes: Results from an Experimental Study 18
Early prediction of contrast-induced acute kidney injury by a "bedside" assessment of Neutrophil Gelatinase-Associated Lipocalin during elective percutaneous coronary interventions 18
Protection from procedural myocardial injury by pre-treatment with atorvastatin is associated with lower expression of adhesion molecules after percutaneous coronary intervention 18
Functional Mitral and Tricuspid Regurgitation across the Whole Spectrum of Left Ventricular Ejection Fraction: Recognizing the Elephant in the Room of Heart Failure 16
Protection from procedural myocardial injury by atorvastatin is associated with lower levels of adhesion molecules after percutaneous coronary intervention: results from the ARMYDA-CAMs (Atorvastatin for Reduction of MYocardial Damage during Angioplasty-Cell Adhesion Molecules) substudy 15
Periprocedural myocardial infarction after percutaneous coronary intervention and long-term mortality: a meta-analysis 13
Rethinking weight loss treatments as cardiovascular medicine in obesity, a comprehensive review 13
Novel Computed Tomography Variables for Assessing Tricuspid Valve Morphology: Results from the TRIMA (Tricuspid Regurgitation IMAging) Study 12
Double anterograde/retrograde approach for embolization of pulmonary arteriovenous malformation presenting with acute respiratory failure 10
Single-territory incomplete surgical revascularization improves regional wall motion of remote ventricular areas: results from a propensity-matched study. 9
Role of polypill in cardiovascular prevention and treatment 8
Statin pretreatment and risk of in-hospital atrial fibrillation among patients undergoing cardiac surgery: a collaborative meta-analysis of 11 randomized controlled trials. 7
Totale 5.933
Categoria #
all - tutte 23.075
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.075


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202262 0 0 2 0 2 0 0 0 0 0 9 49
2022/202394 2 1 16 11 13 2 0 2 1 0 46 0
2023/2024641 1 27 31 31 21 97 51 272 20 42 10 38
2024/20255.134 84 32 90 96 33 84 73 17 141 285 2.009 2.190
2025/20262 2 0 0 0 0 0 0 0 0 0 0 0
Totale 5.933